发布于: 雪球转发：3回复：4喜欢：0
Voyager Therapeutics & Genzyme Announce Major Strategic Collaboration to Develop and Commercialize Novel AAV Gene Therapies for Patients with CNS Disorders #基因治疗#  $SPARK THERAPEUTICS INC(ONCE)$  $uniQure(QURE)$

全部讨论

淡投
2015-02-12 02:10

$uniQure(QURE)$ has multiple clinical CNS pipeline candidates (or rights to in-licence) to including Parkinson's and Sanfilippo B. It also has exclusive collaboration with 4D molecular therapeutics to develop next-gen AAV vectors targeting CNS (and liver)

淡投
2015-02-12 02:03

$100M u/f+ $ 745 m/s
网页链接